Unraveling the Genetic Architecture of Autism Spectrum Disorder: A Review of Twin, Family, and Genome Sequencing Studies

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental disorder affecting social interaction, communication, and behavior. Its etiology includes both genetic and environmental factors. Existing literature indicates that genetics plays a supreme role, with heritability of 60-90%, in which most ASD risk is genetically inherited. Key genes always implicated in ASD include CHD8, SHANK3, SCN2A, and SYNGAP1, which regulate brain development, formation of synapses, neural communication, and chromatin remodeling. Mutations in these genes have been shown to disrupt neural connectivity, leading to the characteristic social and behavioral symptoms of ASD. Genetic mutations in ASD are rare or common. Rare variants exert strong effects to cause large developmental changes, while common variants exert weak individual effects that sum up to contribute to risk. Polygenic risk models have been developed to estimate the combined effect of these variants and to explain variation in symptoms among individuals and families. De novo mutations, which arise spontaneously and are not transmitted, also play a significant role in some cases. Environmental insults like maternal infection, prenatal stress, and exposure to toxins may have the capability to intersect with genetic predisposition, often by epigenetic change like DNA methylation. Advances in sequencing technology like whole-exome sequencing and whole-genome sequencing have allowed identification of these genes and their functional significance. Overall, ASD is the result of the intricate interplay among genetic, epigenetic, and environmental factors. This explanation facilitates early detection, individualized treatments, and the incorporation of genetic information with behavioral and clinical research to enhance overall knowledge of ASD.